F.G. Ivanova, T.I. Nikolaeva, N.I. Spiridonova, L.N. Afanasyeva, P.V. Nikiforov, T.N. Zharnikova
Clinical experience with the use of combination drug therapy in the first line treatment of metastatic non-small cell lung cancer
|
№14 / 2023
|
A.V. Smolin (1), A.Kh. Bekyashev (2), G.L. Kobyakov (3), A.V. Konev (1), S.N. Nikolaeva (1), Yu.E. Shamanskaya (1)
CURRENT POTENTIALS FOR THE TREATMENT OF RELAPSED GLIOBLASTOMA
|
№18 / 2015
|
A.S. Tyulyandina
PRESENT AND FUTURE OF TARGETED THERAPY AS FIRST-LINE TREATMENT OF OVARIAN CANCER
|
№8 / 2013
|
A.A.Kolomeytseva 1, I.M.Gagarin 1, E.V.Reutova 2, V. V. Mochalnikova 1, N. N. Mazurenko 1, V.A.Gorbunova 1
Own Experience Of Use Of Egfr Tyrosine Kinase Inhibitors And Bevacizumab In The Treatment Of Patients With Non-small Cell Lung Cancer
|
№18 / 2012
|
N. N. Semenov
Avastin (bevacizumab) In The Treatment Of Tumors Of The Stomach And Pancreas
|
№18 / 2012
|
Ye.I. Borisova, Ye.I. Chichikov, A.L. Denisenko, S.L. Gutorov
Search For Markers Of Efficiency Of Bevacizumab In Metastatic Colorectal Cancer
|
№17 / 2011
|
G.L. Kobyakov, A.V. Smolin
New Strategies In The Treatment Of Malignant Gliomas: A Brief Review Of Scientific Publications Of The Annual Meeting Of Society The Neuro-oncology (sno 2010) In Montreal
|
№7 / 2011
|
M.M. Konstantinova, V.Ye.Shikina, A.Yu. Makshantsev
Clinical Experience Of Use Of Bevacizumab (avastin) In Patients With Metastatic Breast Cancer With Unidentified Her2/new And Er Pr-receptor Status
|
№7 / 2011
|
M.I. Volkova
Conference Of Renal Cancer Experts: A Review Of Materials
|
№17 / 2010
|
B.V. Kholodov, R.T. Abdullaev, Ye.M. Tarasova, S.K. Gorelyshev, L.V. Shishkina, O.G. Zheludkova, O.V. Klimchuk, O.I. Shcherbenko, A.G. Prityko
Monoclonal Antibodies Bevacizumab (avastin (r)) In Combination Therapy Of Poorly Differentiated Glial Tumors Of Central Nervous System In Children (literature Review And Own Experience)
|
№17 / 2010
|
S.L. Gutorov, Ye.I. Borisova
Maintenance Therapy In Stages Iiib-iv Non-small-cell Lung Cancer
|
№17 / 2010
|
A.F. Urmancheeva
Avastin (bevacizumab) In The Treatment Of Ovarian Cancer
|
№17 / 2010
|